| manufacturer_name | ndc_number | drug_product_description | date_introduced_to_market | wac_at_introduction | marketing_pricing_plan_description | marketing_pricing_plan_non_public_indicator | estimated_number_of_patients | breakthrough_therapy_indicator | priority_review_indicator | acquisition_date | acquisition_price | acquisition_price_non_public_indicator | acquisition_price_comment | general_comments | supporting_documents |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Xeris Pharmaceuticals, INC. | 72065000301 | RECORLEV™ (levoketoconazole) 150mg Tablets 50 in 1 Bottle | 2022-01-26 | 13500.0000 | None | 1 | 25000 | None | None | None | None | None | None | None | None |